APLLTD — Alembic Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual cashflow statement for Alembic Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,493	9,998	13,681	6,201	3,546
Depreciation
Non-Cash Items	53.9	1,210	-823	1,363	2,122
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-580	-8,290	-58.7	-4,908	-1,183
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8,120	4,491	14,634	5,524	7,240
Capital Expenditures	-7,644	-7,349	-6,595	-4,256	-4,434
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	87.7	32.7	-1,793	537	-41.8
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,556	-7,316	-8,388	-3,720	-4,476
Financing Cash Flow Items	-707	3,203	-9,335	-520	-482
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	590	1,549	-5,974	-2,174	-2,620
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,153	-1,272	262	-370	144